Composite bioscore is superior to routine biomarkers and established scoring systems in predicting mortality in adult critically ill patients with secondary sepsis

Author:

Rondovic Goran1,Surbatovic Maja1ORCID,Djordjevic Dragan1,Stanojevic Ivan2,Zeba Snjezana1,Udovicic Ivo1,Djukic Snezana3,Eric Stevan4,Sarac Momir5ORCID,Vojvodic Danilo2ORCID

Affiliation:

1. Military Medical Academy, Clinic for Anesthesiology and Intensive Therapy, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia

2. University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia + Military Medical Academy, Institute for Medical Research, Belgrade, Serbia

3. Clinical Hospital Center Kosovska Mitrovica, Department of Anesthesiology, Kosovska Mitrovica, Serbia

4. Clinical Center Kragujevac, Kragujevac, Serbia

5. University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia + Military Medical Academy, Clinic for Vascular and Endovascular Surgery, Belgrade, Serbia

Abstract

Background/Aim. Sepsis represents a significant global burden, with an estimated 48.9 million cases and 11.0 million sepsis-related deaths recently recorded worldwide. The aim of this observational study was to assess a prognostic value of some readily available routine biomarkers: presepsin, procalcitonin, C-reactive protein (CRP), white blood cell (WBC) count, platelet count, mean platelet volume (MPV), and lactate, as well as their combination regarding the outcome in a cohort of critically ill adult patients with secondary sepsis. Methods. A total of 86 critically ill patients with secondary sepsis due to peritonitis, pancreatitis, and severe trauma, admitted to the surgical intensive care unit, were enrolled in this prospective study. Blood samples for biomarker analysis were collected in three time points: on admission (the 1st day) and on the 3rd, and 5th day after admission. The Sequential Organ Failure Assessment (SOFA) score, the Simplified Acute Physiology Score (SAPS) II, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score were calculated and recorded within the first 24 hours after admission (1st day). SOFA and SAPS II scores were recorded daily. The primary end-point was hospital mortality. Results. Values of each applied score were expectedly significantly higher in non-survivors in all time points. Regarding investigated parameters, only presepsin levels were significantly higher in non-survivors in all time points; MPV levels on the 3rd and 5th day; serum lactate levels on the 3rd day; CRP levels and WBC count on the 5th day. Clinical accuracy of parameters in predicting lethal outcomes was investigated in all time points. On the 1st day, apart from all three scores, only presepsin demonstrated statistically significant discriminative power regarding outcome (AUC of 0.670). Apart from SAPS II and SOFA score, on the 3rd day presepsin, MPV, and lactate (AUCs of 0.716, 0.667, and 0.642, respectively) and on the 5th day presepsin, MPV, CRP, and WBC count (AUCs of 0.790, 0.681, 0.643 and 0.654, respectively) were good predictors of the lethal outcome. Composite bioscore (presepsin, MVP, and lactate) on the 3rd day had the highest AUC of 0.820 in comparison with individual scores and parameters. The independent predictor of the lethal outcome on the 1st day was presepsin (p < 0.05) and on the 3rd day MPV (p < 0.01). Conclusion. Composite bioscore is superior to routine biomarkers and established scoring systems in predicting mortality in adult critically ill patients with secondary sepsis.

Publisher

National Library of Serbia

Subject

Pharmacology (medical),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3